Global market for autoimmune treatments to grow to $55 billion by 2016

The global market for autoimmune treatments reached $34 billion in 2010 and is expected to reach $38.9 billion by 2011.  It will further grow to $55 billion by 2016 at a compounded annual growth rate (CAGR) of 7.2%. The U.S is the largest market for autoimmune treatments and holds a 43% share of the global market. It will sustain its position and will hold a 44% share in 2016.

Learn about the products and therapies currently used or under development for treatment of a variety of autoimmune diseases. Also learn about the global autoimmune market by product segment, disease, and geographical region. Company profiles are provided as well...

Use this report to:

• Receive in-depth analysis and forecasts of the global autoimmune products market
• Determine products and therapies currently used or under development for treatment of a variety of autoimmune diseases
• Understand the autoimmune market by disease and by treatment, with supporting tables and figures to illustrate projected growth
• Analyze information on autoimmune treatment assistive technologies, patents and regulations.

To provide further information about this report we offer a Complimentary Introduction, available from our Website. To download, simply click here, go to the Table of Contents tab, add the complimentary introduction to your cart, and confirm your order.

GLOBAL MARKET FOR AUTOIMMUNE TREATMENTS BY GEOGRAPHICAL AREA, 2011 AND 2016

(%)